AI assistant
Sending…
DEXCOM INC — Director's Dealing 2014
Apr 9, 2014
30198_dirs_2014-04-09_08db6341-5b58-471f-b20c-c41760a2cb16.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2014-04-07
Reporting Person: MOY JEFFREY (SVP, Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-04-07 | Common Stock | M | 1.0 | $3.19 | Acquired | 135102 | Indirect |
| 2014-04-07 | Common Stock | M | 6463.0 | $6.33 | Acquired | 141565 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-04-07 | Incentive Stock Option (right to buy) | $3.19 | M | 1.0 | Disposed | 2018-12-11 | Common Stock (1) | Direct |
| 2014-04-07 | Incentive Stock Option (right to buy) | $6.33 | M | 6463.0 | Disposed | 2018-09-24 | Common Stock (6463) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 97916 | Direct |
Footnotes
F1: Shares are held by the Moy Family Trust U/A/D 12/09/2013, with respect to which the reporting person is a trustee.
More from DEXCOM INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 17